Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.53), $0.04 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Rockwell Medical Technologies (RMTI) PT Lowered to $20 at Maxim Group
• Amer Sports (AS) 89K contracts trade